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Abstract
Background: Several patients with the 2p16.1p15 microdeletion syndrome have been reported. However,
microduplication in the 2p16.1p15 chromosomal region has only been reported in one case, and milder clinical
features were present compared to those attributed to 2p16.1p15 microdeletion syndrome. Some additional cases
were deposited in DECIPHER database.
Case presentation: In this report we describe four further cases of 2p16.1p15 microduplication in four unrelated
probands. They presented with mild gross motor delay, delayed speech and language development, and mild
dysmorphic features. In addition, two probands have macrocephaly and one a congenital heart anomaly. Newly
described cases share several phenotype characteristics with those detailed in one previously reported
microduplication case.
Conclusion: The common features among patients are developmental delay, speech delay, mild to moderate
intellectual disability and unspecific dysmorphic features. Two patients have bilateral clinodactyly of the 5th finger
and two have bilateral 2nd-3rd toes syndactyly. Interestingly, as opposed to the deletion phenotype with some
cases of microcephaly, 2 patients are reported with macrocephaly. The reported cases suggest that
microduplication in 2p16.1p15 chromosomal region might be causally linked to developmental delay, speech delay,
and mild intellectual disability.
Keywords: 2p16.1p15, Molecular karyotyping, Array CGH, microduplication, Duplication, Developmental delay,
Macrocephaly
Background
The implementation of molecular karyotyping (array CGH;
aCGH) into the routine genetic diagnostics of children with
intellectual disability/developmental delay with or without
various congenital anomalies and dysmorphic features has
considerably increased the diagnostic utility of genetic test-
ing, as well as the pace of identification of novel microdele-
tion and microduplication syndromes [1, 2]. In parallel, it
enabled us to further delineate genes or groups of genes
whose deletion or duplication is associated with a specific
phenotype; the recurrent microdeletion and microduplica-
tion syndromes.
Herein reported region of 2p16.1p15 was identified
as a new microdeletion syndrome (OMIM #612513)
already in 2007, when two patients with 4.5 Mb and
5.7 Mb de novo deletions were reported [3]. Since
then more than 10 additional patients with different
deletion sizes and breakpoints were reported in the
literature, with the clinical phenotype including dif-
ferent levels of intellectual disability and develop-
mental delay, speech delay, microcephaly, structural
brain anomalies, neuromotor deficits, visual
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impairment, strabismus, renal anomalies, camptodac-
tyly, and dysmorphic features [4–10].
On the other hand, the microduplication of the same
region 2p16.1p15 has only been recently described in
one case [11]. The authors report a relatively milder
clinical phenotype as compared to the above mentioned
clinical features of the individuals with the deletion in
this chromosomal region. As only one case has been ex-
tensively described, the phenotype associated to the
2p16.1p15 microduplication has not been delineated as a
specific disorder.
We present four further cases of microduplica-
tion 2p16.1p15 and compare the clinical features of
our patients with those previously described. In
addition, some patients are described in DECIPHER
and ClinGen databases and are included in the
report as well (Fig. 2/Table 1). With growing number
of patients further evidence is provided that
2p16.1p15 microduplication might be linked to de-
velopmental delay, speech delay, and mild intellec-
tual disability.
Cases presentation
Patient 1
The first patient is a male child of healthy non con-
sanguineous parents. He was born at term after an
uneventful pregnancy with birth weight 3.244 g
(25-50P), birth length 50.3 cm (25-50P) and head
circumference 38.5 cm (97P). At birth he presented
mild jaundice, reduced movements and some initial
feeding difficulties. Thoracic and abdominal ultra-
sound were normal.
The developmental milestones in the boy were de-
layed - he was able to sit independently at 11 months
of age and he started to walk at 21 months. The first
sounds and signs of speech/language development
were described after 14 months of age. At 4 years of
age he was not able to generate complete sentences.
A mild intellectual disability was present. His growth
parameters were within the normal range. Mild dys-
morphic features were described - receding forehead,
broad and high nasal bridge, sparse eyebrows, epi-
canthal folds, straight eyelashes and pronounced phil-
trum (Fig. 1a). He has bilateral clinodactyly of the 5th
finger and bilateral 2nd-3rd toes syndactyly. He was
referred to genetic counseling for delayed global de-
velopment. Informed consent for the study was ob-
tained from the parents.
Microarray analysis (180 K CGH array, Agilent
Technologies-Fig. 1b) revealed a de novo microduplica-
tion of 2,00 Mb in chromosome 2p16.1p15 region
(arr[GRCh37] 2p16.1p15(60113626_62111114)× 3 dn).
No other pathogenic genomic imbalance was detected in
the proband’s sample.
Patient 2
The second patient is a 5-year old boy, born as a first
child to healthy non-consanguineous parents. The
mother reported two previous early spontaneous abor-
tions. Otherwise, the family history is unremarkable. He
was born after an uneventful pregnancy in the 37th week
of gestation after a spontaneous start of the delivery.
The boy’s birth weight was 2430 g (10-25P), birth length
46 cm (10-25P), and head circumference 34.5 cm
(75-90P). He had gastroesophageal reflux in the first few
months, the abdominal ultrasound was normal. Due to
apnoic attacks the boy was administered to hospital at
the age of 5 months. The pH-metry confirmed gastro-
esophageal reflux, ECG and CMCRF were normal. The
neurologist described a mild hypertonus and related
mild motor delay. He sat independently at 9 months of
age and he started walking at 20 months of age. The par-
ents noted shortness of breath and tiredness after simple
physical tasks, therefore, he was evaluated by a paediat-
ric cardiologist. Two haemodynamically significant ASDs
were noted and a slightly dilated right ventricle; correct-
ive surgery is planned. The tests of acylcarnitine profiles
and aminoacids in blood and organic acid in urine were
normal. At the age of four his height and weight were in
the normal range (height 99.2 cm (17P), weight 16.1 kg
(46P)), however, the head circumference showed macro-
cephaly - 53.8 cm (>97P).
Microarray analysis (180 K CGH array, Agilent
Technologies- Fig. 1b) revealed a de novo microduplica-
tion of 2.06 Mb in chromosome 2p16.1p15 region
(arr[GRCh37] 2p16.1p15(60308869_62368583)× 3 dn).
No other pathogenic genomic imbalance was detected
in the proband’s sample.
Patient 3 - DECIPHER ID323264
This male patient was born after an uneventful preg-
nancy in the 36th week of gestation with birth weight
2820 g (50P), birth length 51 cm (90P), and head cir-
cumference 36.5 cm (97P). He walked at 18 months and
showed speech delay. He has learning difficulties and at-
tends a special education program. At 15 years his growth
parameters were in the normal range (weight 60 kg
(50-75P), height 165 cm (25-50P), head circumference
55 cm (25P). Microarray analysis revealed a microduplica-
tion of 1.61 Mb in chromosome 2p16.1p15 region, con-
firmed by FISH (arr[GRCh37] 2p16.1p15(60236241–
61,848,845)× 3 mat). Also, his mother was a carrier of the
duplication with learning difficulties, epilepsy and obesity.
No further details about her phenotype were available.
Patient 4 - DECIPHER ID258333
This male patient was born at term after an uneventful
pregnancy. He displayed early hypotonia and neonatal
feeding difficulties. He walked at 20 months and showed
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speech delay. Later, moderate intellectual disability was
diagnosed. In the childhood, he had recurrent infections
with neutropenia and thrombocytopenia. He has small
ears and small hands. At 33 years his growth parameters
were as follows: height 192 cm (95P), weight 95 kg
(95P), head circumference 63.5 cm (>97P). Microarray
analysis revealed a microduplication of 2.09 Mb in
chromosome 2p16.1p15 region, confirmed by FISH
(arr[GRCh37] 2p16.1p15(59938734–62,025,519)× 3 dn).
Comparison with overlapping cases
The Database of Genomic Variants (DGV) [12] was
checked for the presence of similar CNVs in control
populations and none were revealed. A search through
several databases, DECIPHER [13], ClinGen [14] and
scientific literature indexed in PubMed (http://
www.ncbi.nlm.nih.gov/pubmed) was performed.
According to all cases reported in the literature or depos-
ited in databases with phenotype description (Table 1),
there are 3 additional cases with overlapping duplications.
One presented in detail as a case report [11] and 2 depos-
ited in DECIPHER database. All were de novo. There are 4
additional cases, 1 in DECIPHER database with no pheno-
type data and 3 in ClinGen/ISCA database, listed under cat-
egory “Developmental delay and additional significant
developmental and morphological phenotypes referred for
genetic testing”. All CNVs are presented in Fig. 2.
The common features among the 7 patients with de-
scribed phenotypic details are developmental delay,
speech delay, mild to moderate intellectual disability,
and unspecific dysmorphic features. Two patients have
bilateral clinodactyly of the 5th finger and two have bi-
lateral 2nd-3rd toes syndactyly. Interestingly, as opposed
to the deletion phenotype, where microcephaly is re-
ported in approximately 44% of patients [9], 2 out of 7
patients with duplication have macrocephaly. Such
mirror phenotypes are often reported in the cases of
microdeletion and microduplication syndromes of
common region [15, 16].
The smallest region of overlap among reported cases
encompasses 9 genes: BCL11A, PAPOLG, REL, PUS10,
PEX13,KIAA1841, C2orf74, ASHA2, USP34, among them
BCL11A and PEX13 are OMIM Morbid genes. Gene
PEX13 (OMIM*601789) is linked to the autosomal re-
cessive Peroxisome biogenesis disorder 11A and 11B.
The second OMIM Morbid BCL11A has just recently
been linked to new autosomal dominant Dias-Logan
syndrome [17], with suggested clinical syndrome of at
least mild dysmorphisms with intellectual disability and
persistence of fetal haemoglobin. The type of mutation
(missense mutations, truncating mutations, bigger dele-
tions) partially defines the Dias-Logan phenotype, whereas
the deletions of the neighbouring regions present as a
2p16.1p15 microdeletion syndrome with additional
Fig. 1 Facial dysmorphism of case 1 and the array CGH profiles in both probands. a The details about facial dysmorphis are presented in Table 1;
b The array CGH results are presented for both Case 1 and Case 2. The reported duplications are almost the same. Case 1 - arr[GRCh37]
2p16.1p15(60113626_62111114)× 3 dn; Case 2 - arr[GRCh37] 2p16.1p15(60308869_62368583)× 3 dn
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clinical features, as described above. The BCL11A is
highly expressed in human cerebral cortex, hippocam-
pus and cerebellum and the zebrafish knockdown
models developed microcephaly and showed size re-
duction [18]. The 2p16.1p15 microdeletion syndrome
patients have broad size range of deleted regions, and
in addition to BCL11A, one more gene has shown
potential link to the phenotype after extensive studies.
Knockdown of REL in zebrafish resulted in specific
structural brain anomalies, abnormal growth, and dys-
morphisms. These findings are in accordance with
known roles of REL in NF-kappaB pathway and mem-
ory formation [18].
When trying to decipher the meaning of duplications,
search for copy number gain of selected genes was per-
formed. There are currently no additional data (apart
from the CNV sizes and some phenotype features of
reported cases) available for the above mentioned
genes in the literature. Telomeric borders of herein
detailed duplications, including those from available
databases with no specific phenotype data, do not dif-
fer by gene content (Fig. 2). On the centromeric
border, there are 4 genes that are not uniformly du-
plicated in all cases, namely XPO1 (OMIM#602559),
FAM16A1 (OMIM#613596), CCT4 (OMIM#605142)
and COMMD1 (OMIM#607238). FAM16A1 is a
known morbid gene, linked to autosomal recessive
Retinitis pigmentosa 28. The other 3 genes have not
been linked to human disease before and there are no
individual phenotype features that could be linked to
specific duplication sizes in the group of patients that
are included in this report. Most likely explanation is
that these genes do not cause significant additional
clinical phenotype when present in 3 copies. Less
likely, these might be increased gene dosage sensitive
genes, but specific phenotype has not been sufficiently
described in presented patients.
Conclusion
Despite of almost two decades of molecular karyotyping
in the group of individuals with developmental delay, in-
tellectual disability, dysmorphic features and additional
clinical characteristics, novel rare copy number varia-
tions are still identified. Their absence in the databases
of normal copy number variation covering numerous
populations renders further proof of potential signifi-
cance or causality for specific phenotypes. Herein we
report in detail 4 additional cases of 2p16.1p15 microdu-
plication, which has been reported only once in the lit-
erature so far [11]. Each novel case of such a rare CNV
provides important insights for clinicians, as well as for
deciphering the human genome.
Together with previously reported data, our results sug-
gest that the 2p16.1p15 microduplication might be linked
to developmental delay, speech delay, mild to moderate
intellectual disability, and unspecific dysmorphic features.
Further cases are needed to decipher its clinical implica-
tions and decide if it represents a new clinical entity.
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